TRN-157

DRUG2 trials

Sponsors

Theron Pharmaceuticals, Inc.

Conditions

AsthmaChronic Obstructive Pulmonary Disease

Phase 1

Single Ascending Dose Study of TRN-157 in Healthy Subjects

CompletedNCT02133339

Theron Pharmaceuticals, Inc.Chronic Obstructive Pulmonary Disease

Start: 2014-05-31End: 2014-09-30Updated: 2014-10-31

Phase 2

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

CompletedNCT02382510

Theron Pharmaceuticals, Inc.Asthma

Start: 2015-04-30End: 2016-03-31Updated: 2017-05-09